Wells Fargo’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-50
| Closed | -$521 | – | 7711 |
|
|
2023
Q2 | $521 | Hold |
50
| – | – | ﹤0.01% | 6480 |
|
|
2023
Q1 | $528 | Hold |
50
| – | – | ﹤0.01% | 6544 |
|
|
2022
Q4 | $627 | Hold |
50
| – | – | ﹤0.01% | 6322 |
|
|
2022
Q3 | $1K | Hold |
50
| – | – | ﹤0.01% | 6490 |
|
|
2022
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 6642 |
|
|
2022
Q1 | $2K | Hold |
50
| – | – | ﹤0.01% | 6710 |
|
|
2021
Q4 | $2K | Sell |
50
-40
| -44% | -$2.11K | ﹤0.01% | 6921 |
|
|
2021
Q3 | $7K | Hold |
90
| – | – | ﹤0.01% | 6309 |
|
|
2021
Q2 | $8K | Sell |
90
-100
| -53% | -$9.51K | ﹤0.01% | 6212 |
|
|
2021
Q1 | $22K | Buy |
190
+140
| +280% | +$15.5K | ﹤0.01% | 6122 |
|
|
2020
Q4 | $2K | Hold |
50
| – | – | ﹤0.01% | 6295 |
|
|
2020
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 6155 |
|
|
2020
Q2 | $4K | Buy |
50
+42
| +525% | +$3.84K | ﹤0.01% | 6031 |
|
|
2020
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 6920 |
|
|
2019
Q4 | $1K | Hold |
8
| – | – | ﹤0.01% | 6285 |
|
|
2019
Q3 | $1K | Sell |
8
-2
| -20% | -$433 | ﹤0.01% | 6309 |
|
|
2019
Q2 | $3K | Hold |
10
| – | – | ﹤0.01% | 6134 |
|
|
2019
Q1 | $5K | Buy |
10
+2
| +25% | +$777 | ﹤0.01% | 5752 |
|
|
2018
Q4 | $2K | Hold |
8
| – | – | ﹤0.01% | 6220 |
|
|
2018
Q3 | $1K | Hold |
8
| – | – | ﹤0.01% | 6332 |
|
|
2018
Q2 | $2K | Hold |
8
| – | – | ﹤0.01% | 6205 |
|
|
2018
Q1 | $1K | Hold |
8
| – | – | ﹤0.01% | 6297 |
|
|
2017
Q4 | $2K | Hold |
8
| – | – | ﹤0.01% | 6209 |
|
|
2017
Q3 | $2K | Hold |
8
| – | – | ﹤0.01% | 6174 |
|
|
2017
Q2 | $1K | Hold |
8
| – | – | ﹤0.01% | 6150 |
|
|
2017
Q1 | $2K | Hold |
8
| – | – | ﹤0.01% | 6181 |
|
|
2016
Q4 | $3K | Hold |
8
| – | – | ﹤0.01% | 6054 |
|
|
2016
Q3 | $3K | Buy |
+8
| New | +$2.8K | ﹤0.01% | 6009 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6370 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6481 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 6458 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6497 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 6266 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 6401 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 6456 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 6381 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 6323 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 6112 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 5961 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 5876 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 5479 |
|
Other funds holding CSCI
TSS
EDRH
FDCDDQ
Wells Fargo's CSCI Position: Q3 2023 in Review
Wells Fargo sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2023, closing a stake of 50 shares — an estimated $521 sold.
Wells Fargo first reported a position in CSCI in Q3 2016 and held it in 28 quarters. The position peaked at $22K in Q1 2021. 14 funds tracked by Wall St. Rank hold CSCI as of Q3 2023.
- Wells Fargo reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Wells Fargo sold 50 COSCIENS Biopharma Inc. Common Stock shares in Q3 2023, an estimated $521.
- Wells Fargo first reported a position in COSCIENS Biopharma Inc. Common Stock in Q3 2016 and held it in 28 quarters.
- Wells Fargo's COSCIENS Biopharma Inc. Common Stock position peaked at $22K in Q1 2021.
- 14 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2023.
Based on Wells Fargo's 13F filing for Q3 2023, filed 13 Nov 2023.